ARCHIVES OF

THE BALKAN MEDICAL UNION

The official journal of the Balkan Medical Union, since 1935

Citation Abbreviation:

Arch Balk Med Union

Direct oral anticoagulants in very elderly patients with atrial fibrillation: one-year outcomes

0

Introduction. Very elderly patients (≥85 years) with atrial fibrillation (AF) carry a high thromboembolic burden. Outcome data in very elderly patients treated with direct oral anticoagulants (DOACs) remain scarce.
The objective of the study was to compare one-year outcomes across age groups and identify predictors of major adverse cardiovascular events (MACE) in AF patients receiving DOACs, with emphasis on those aged ≥85 years.
Material and methods. We conducted a single-center cohort study of 212 patients (median age 76 years; 53.5% female) with non-valvular AF receiving DOACs. Patients were stratified into three age groups: <75, 75–84, and ≥85 years. The primary endpoint was MACE, defined as stroke or systemic thromboembolism, myocardial infarction, peripheral arterial embolism, major bleeding, or all-cause mortality within 12 months. Cox proportional hazards regression was used to identify predictors.
Results. The age distribution was: 42.4% of patients <75 yo, 38.7% between 75–84 yo, and 18.9% ≥85 yo. During 12-month follow-up, MACE occurred in 42 patients (19.8%). The incidence increased significantly with age (11.1% in those aged <75 years, 19.5% in those 75–84 years, and 40.0% in those ≥85 years; p=0.001). In univariate analysis, age ≥85 years was associated with higher risk of MACE (hazard ratio [HR] 2.86, 95% confidence interval [CI] 1.53–5.34; p=0.001), but this association was not significant after adjustment (HR 1.52, 95% CI 0.74–3.11; p=0.250). Independent predictors of MACE included prior bleeding (HR 4.14, 95% CI 1.68–10.20; p=0.002) and lower estimated glomerular filtration rate (per 1 mL/min/1.73 m² decrease: HR 0.98, 95% CI 0.96–0.99; p=0.009). Off-label DOAC dosing was not associated with outcomes.
Conclusions. Patients ≥85 years old had the highest crude event rates, but age itself was not an independent predictor after adjustment. Prognosis was driven mainly by renal dysfunction and prior bleeding, underscoring the need for individualized anticoagulation strategies in the very elderly.
Keywords: atrial fibrillation, direct oral anticoagulant, major bleeding, thromboembolism, very elderly.

Address for correspondence:
Truong Huy HOANG 
Department of Internal Medicine, Faculty of Medicine, Pham Ngoc Thach University of Medicine
Address: 72410, 2 Duong Quang Trung Street, Hoa Hung Ward, Ho Chi Minh City, Vietnam E-mail: truonghh@pnt.edu.vn

Share.

Comments are closed.

Hoang TH, Le TH, Le TC. Direct oral anticoagulants in very elderly patients with atrial fibrillation: one-year outcomes. Arch Balk Med Union. 2025;60(4):465-474. https://doi.org/10.31688/ABMU.2025.60.4.02